Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by Wino115on May 14, 2021 5:59pm
186 Views
Post# 33208508

RE:RE:RE:RE:AIGH Capital Management new stake reported

RE:RE:RE:RE:AIGH Capital Management new stake reportedThose 4 bought in the deal, well below market and with a warrant also with a low strike price.  The chance of them losing money in the medium term was close to zero.  There's probably not been one day their investment hasn't been in the positive.  That's a bargain alright!

canadapiet wrote: Wino 115 wrote:

It's not too hard to find 4 guys who love a bargain, afterall. 



Bargain???
Are you sure???
That has to be seen in the future, isn't it?? 
How long are they on the market?? Look for the past 10? 12? 15 years????? How long is Mr. SPCEO telling the story of "the lift off"...........????!!!
It was a must own after Egrifta! It was a must own after Trogarzo! It is a must own now because of premature oncology asset and a "lucky" Nash asset ????

They sell 2 products for a negative income.......
They burn a lot of money........
They, the great management, costs the shareholders a lot (way to much) of money! 
Etc.


Good luck 






<< Previous
Bullboard Posts
Next >>